{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:27:15Z","timestamp":1778588835235,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T00:00:00Z","timestamp":1705276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.heliyon.2024.e24774","type":"journal-article","created":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T04:26:48Z","timestamp":1705811208000},"page":"e24774","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Psoriasis and risk of central neurological disorders in European populations: A mendelian randomization analysis"],"prefix":"10.1016","volume":"10","author":[{"given":"Ya","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huimin","family":"Chong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.heliyon.2024.e24774_bib38","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1055\/s-0031-1287867","article-title":"Organ failure: central nervous system","volume":"32","author":"Naval","year":"2011","journal-title":"Semin. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e24774_bib39","doi-asserted-by":"crossref","first-page":"e1695","DOI":"10.1002\/wnan.1695","article-title":"Brain penetrating peptides and peptide-drug conjugates to overcome the blood-brain barrier and target CNS diseases","volume":"13","author":"Zhou","year":"2021","journal-title":"Wiley Interdiscip. Rev.Nanomedicine and nanobiotechnology"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e24774_bib3","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.ncl.2021.04.004","article-title":"Inflammatory diseases of the central nervous system","volume":"39","author":"Malani Shukla","year":"2021","journal-title":"Neurol. Clin."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e24774_bib4","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a033118","article-title":"Clinical Neurology and epidemiology of the major Neurodegenerative diseases","volume":"10","author":"Erkkinen","year":"2018","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.heliyon.2024.e24774_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2019.101452","article-title":"Differential diagnosis of multiple sclerosis and other inflammatory CNS diseases","volume":"37","author":"Wildner","year":"2020","journal-title":"Multiple sclerosis and related disorders"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e24774_bib6","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nri2550","article-title":"Autoimmune T cell responses in the central nervous system","volume":"9","author":"Goverman","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"10281","key":"10.1016\/j.heliyon.2024.e24774_bib7","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"Griffiths","year":"2021","journal-title":"Psoriasis. Lancet (London, England)"},{"key":"10.1016\/j.heliyon.2024.e24774_bib8","first-page":"m1590","article-title":"National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study","volume":"369","author":"Parisi","year":"2020","journal-title":"BMJ (Clinical research ed)"},{"key":"10.1016\/j.heliyon.2024.e24774_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15382","article-title":"Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants","volume":"8","author":"Tsoi","year":"2017","journal-title":"Nat. Commun."},{"issue":"5S","key":"10.1016\/j.heliyon.2024.e24774_bib10","first-page":"18","article-title":"Psoriasis risk factors and triggers","volume":"102","author":"Lee","year":"2018","journal-title":"Cutis"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e24774_bib11","doi-asserted-by":"crossref","first-page":"6454","DOI":"10.1038\/s41598-020-63550-2","article-title":"Increased risk of Alzheimer's disease in patients with psoriasis: a nationwide population-based cohort study","volume":"10","author":"Kim","year":"2020","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e24774_bib12","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jaad.2012.12.961","article-title":"Psoriasis is associated with an increased risk of parkinsonism: a population-based 5-year follow-up study","volume":"68","author":"Sheu","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e24774_bib13","first-page":"1","volume":"32","author":"Smith","year":"2003","journal-title":"Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? International journal of epidemiology"},{"key":"10.1016\/j.heliyon.2024.e24774_bib14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev-genom-083117-021731","article-title":"Inferring causal relationships between risk factors and outcomes from genome-wide association study data","volume":"19","author":"Burgess","year":"2018","journal-title":"Annu. Rev. Genom. Hum. Genet."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e24774_bib15","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s40471-017-0128-6","article-title":"Recent developments in mendelian randomization studies","volume":"4","author":"Zheng","year":"2017","journal-title":"Current epidemiology reports"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e24774_bib16","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/sim.3034","article-title":"Mendelian randomization: using genes as instruments for making causal inferences in epidemiology","volume":"27","author":"Lawlor","year":"2008","journal-title":"Stat. Med."},{"issue":"19","key":"10.1016\/j.heliyon.2024.e24774_bib17","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian randomization","volume":"318","author":"Emdin","year":"2017","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e24774_bib18","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jaad.2015.08.039","article-title":"Increased risk of migraine in patients with psoriasis: a Danish nationwide cohort study","volume":"73","author":"Egeberg","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e24774_bib19","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1515\/revneuro-2017-0108","article-title":"Neurological and psychiatric disorders in psoriasis","volume":"29","author":"Amanat","year":"2018","journal-title":"Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e24774_bib20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/0333102410373159","article-title":"Co-morbidity of migraine with somatic disease in a large population-based study","volume":"31","author":"Le","year":"2011","journal-title":"Cephalalgia : an international journal of headache"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e24774_bib21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/jdv.14472","article-title":"Psoriasis and migraine","volume":"32","author":"Capo","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol. : JEADV"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e24774_bib22","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/bjd.16031","article-title":"Neuropsychiatric comorbidity among adolescents with psoriasis","volume":"178","author":"Galili","year":"2018","journal-title":"Br. J. Dermatol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e24774_bib23","first-page":"1037","volume":"165","author":"Yang","year":"2011","journal-title":"Medical comorbidity associated with psoriasis in adults: a population-based study. The British journal of dermatology"},{"issue":"18","key":"10.1016\/j.heliyon.2024.e24774_bib24","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1212\/WNL.0b013e3181c06635","article-title":"Autoimmune disease and risk for Parkinson disease: a population-based case-control study","volume":"73","author":"Rugbjerg","year":"2009","journal-title":"Neurology"},{"issue":"1\u20134","key":"10.1016\/j.heliyon.2024.e24774_bib25","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000333222","article-title":"Subsequent risks of Parkinson disease in patients with autoimmune and related disorders: a nationwide epidemiological study from Sweden","volume":"10","author":"Li","year":"2012","journal-title":"Neurodegener. Dis."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e24774_bib26","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4103\/0019-5154.177771","article-title":"Risk of Parkinson's disease among patients with psoriasis: a systematic review and meta-analysis","volume":"61","author":"Ungprasert","year":"2016","journal-title":"Indian J. Dermatol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e24774_bib27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000448402","article-title":"Epidemiology of Parkinson's disease: a population-based study in Primary care in Italy","volume":"47","author":"Pupillo","year":"2016","journal-title":"Neuroepidemiology"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e24774_bib28","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1212\/NXI.0000000000000099","article-title":"Glial cells express nuclear nrf2 after fumarate treatment for multiple sclerosis and psoriasis","volume":"2","author":"Metz","year":"2015","journal-title":"Neurology(R) neuroimmunology & neuroinflammation"},{"key":"10.1016\/j.heliyon.2024.e24774_bib29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.msard.2017.02.012","article-title":"Increased incidence and prevalence of psoriasis in multiple sclerosis","volume":"13","author":"Marrie","year":"2017","journal-title":"Multiple sclerosis and related disorders"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e24774_bib30","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/JID.2015.350","article-title":"Risk of multiple sclerosis in patients with psoriasis: a Danish nationwide cohort study","volume":"136","author":"Egeberg","year":"2016","journal-title":"J. Invest. Dermatol."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e24774_bib31","doi-asserted-by":"crossref","first-page":"e397","DOI":"10.1111\/jdv.14205","article-title":"Multiple sclerosis association with psoriasis: a large U.S. population, single centre, retrospective cross-sectional study","volume":"31","author":"Guido","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol. : JEADV"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e24774_bib32","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1111\/jdv.14403","article-title":"Psoriasis comorbidity affects multiple sclerosis neurological progression: a retrospective case - control analysis","volume":"31","author":"Miron","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol. : JEADV"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e24774_bib33","first-page":"1005","article-title":"Progressive multifocal leukoencephalopathy in two psoriasis patients treated with efalizumab","volume":"9","author":"Gadzia","year":"2010","journal-title":"J. Drugs Dermatol. JDD : J. Drugs Dermatol. JDD"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e24774_bib34","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000249365","article-title":"Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes","volume":"172","author":"Lindeg\u00e5rd","year":"1986","journal-title":"Dermatol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e24774_bib35","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jamaneurol.2014.188","article-title":"Population-level evidence for an autoimmune etiology of epilepsy","volume":"71","author":"Ong","year":"2014","journal-title":"JAMA Neurol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e24774_bib36","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1365-2133.2010.09897.x","article-title":"Comedication related to comorbidities: a study in 1203 hospitalized patients with severe psoriasis","volume":"159","author":"Gerdes","year":"2008","journal-title":"Br. J. Dermatol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e24774_bib37","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/ped.13309","article-title":"Pediatric psoriasis: Should we be concerned with comorbidity? Cross-sectional study","volume":"59","author":"Kelati","year":"2017","journal-title":"Pediatr. Int. : official journal of the Japan Pediatric Society"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024008053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024008053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T06:15:19Z","timestamp":1775456119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024008053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S2405844024008053"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e24774","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psoriasis and risk of central neurological disorders in European populations: A mendelian randomization analysis","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e24774","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e24774"}}